When people discuss influential business executives, their career paths can reveal a great deal about how leadership develops in different industries. Tom Kennedy and Emma Walmsley are two examples of executives who built long careers in major international organizations, but their professional backgrounds and areas of expertise are notably different.
Tom Kennedy became recognized for his leadership in aerospace, defense, engineering, and advanced technology through his long association with Raytheon. Emma Walmsley developed her career through international consumer businesses before moving into healthcare and eventually becoming chief executive of GSK.
Examining their careers together provides an interesting look at executive development, corporate transformation and the different experiences that can lead to senior leadership positions.
Tom Kennedy’s Engineering-Based Career
Thomas A. Kennedy developed his career around engineering and technology. He joined Raytheon in 1983 and spent decades working in different technical and management positions before reaching the company’s highest leadership levels.
His academic background was also closely connected to engineering. Kennedy earned a bachelor’s degree in electrical engineering from Rutgers University, a master’s degree from the Air Force Institute of Technology and a doctorate in engineering from UCLA.
His early professional experience included radar development and other technologically complex areas. Over time, his responsibilities expanded beyond engineering into program management and business leadership.
This gradual progression is an important part of Kennedy’s professional story. Rather than moving immediately into general corporate management, he developed substantial experience within the technology and defense environment before taking on broader executive responsibilities.
Kennedy’s Leadership at Raytheon
Kennedy became Raytheon’s chief executive officer in 2014 and subsequently served as chairman. His tenure placed him in charge of a major company operating across aerospace, defense and technology markets.
During his leadership, Raytheon continued to focus heavily on advanced technological capabilities and defense-related systems. His experience in engineering remained relevant as the company dealt with increasingly sophisticated technology and changing demands across its markets.
Kennedy’s career also reached an important transition point when Raytheon merged with United Technologies in 2020. The transaction resulted in the creation of Raytheon Technologies, which was later renamed RTX.
Following the merger, Kennedy served as executive chairman of the newly created company before leaving the role in 2021. Public corporate records also show that he later became a director of Textron.
Emma Walmsley’s Different Route to Leadership
Emma Walmsley’s professional journey took a very different direction.
Rather than beginning in engineering or pharmaceutical research, Walmsley built her early career in marketing and international consumer business. She studied Classics and Modern Languages at the University of Oxford and then spent approximately 17 years at L’Oréal.
During her time at L’Oréal, she worked in several international markets and developed substantial experience in marketing and general management. Her international exposure became an important foundation for her later executive career.
Walmsley joined GSK in 2010 and initially became involved with its consumer healthcare operations. She subsequently took on increasingly senior responsibilities and eventually became chief executive of GSK in 2017.
Her career therefore provides an example of how commercial and international management experience can lead into senior leadership at a global healthcare company.
Walmsley and the Transformation of GSK
Walmsley’s time at GSK was marked by significant changes in the company’s business structure and strategic direction.
One of the best-known developments was the separation of GSK’s consumer healthcare business. The resulting company, Haleon, was listed independently in 2022. Walmsley had been closely involved in the consumer-healthcare business and later in the process that separated it from GSK.
After the separation, GSK concentrated more strongly on biopharmaceuticals, including medicines and vaccines. GSK described Walmsley’s tenure as a period of significant changes to its portfolio and pipeline, with increased emphasis on specialty medicines and vaccines.
Her leadership therefore occurred during a period when GSK was redefining its identity and concentrating on a more focused healthcare business.
Comparing Tom Kennedy and Emma Walmsley
Although Kennedy and Walmsley worked in very different industries, their careers share several broad characteristics.
Both spent many years developing expertise before reaching the chief executive level. Both worked for large multinational organizations and eventually became responsible for complex operations involving large numbers of employees, customers and stakeholders.
The major difference lies in their professional foundations.
Kennedy’s career was built primarily around engineering, defense technology and corporate operations. Walmsley’s career began with marketing and international consumer business before moving into healthcare.
This contrast demonstrates that there is no single educational or professional route to executive leadership.
Education and Professional Development
The career histories of Tom Kennedy and Emma Walmsley also show two contrasting approaches to professional development.
Kennedy’s education was highly technical. His engineering degrees and early work in radar technology gave him specialist knowledge that was directly connected to the industry in which he later became an executive.
Walmsley’s educational background was in humanities rather than science or medicine. Her professional development came through international business experience, marketing and general management.
This distinction is particularly interesting because GSK operates in a sector heavily dependent on scientific research, while its CEO came through a commercial rather than scientific career path.
It highlights how large organizations often require leadership capabilities that extend beyond technical specialization. Strategy, communication, organizational management, commercial understanding and international experience can all become important at the executive level.
Also Visits: BrightMagazine
Two Different Industries
Another useful way to understand Tom Kennedy and Emma Walmsley is to examine the industries in which they spent much of their careers.
Kennedy’s aerospace and defense environment involves advanced engineering, government customers, highly specialized systems and long development cycles. Companies operating in this sector often manage complicated technology portfolios and significant regulatory and security requirements.
Walmsley’s healthcare environment presents a different set of challenges. Pharmaceutical and biopharmaceutical companies must deal with research, clinical development, manufacturing, regulation, intellectual property and global healthcare systems.
The two careers therefore demonstrate how leadership principles can operate across very different business environments.
Corporate Change and Executive Leadership
Both careers were also connected to significant organizational change.
Kennedy’s later Raytheon career included the company’s merger with United Technologies, creating Raytheon Technologies in 2020. That transaction represented a major structural change for both organizations and required leadership during a complicated integration process.
Walmsley, meanwhile, oversaw GSK during a major restructuring that included the separation of its consumer-healthcare activities into Haleon and a stronger focus on biopharmaceutical operations.
In both situations, executive leadership involved more than maintaining existing operations. Strategic decisions affected company structures, portfolios and long-term priorities.
Emma Walmsley’s Leadership Transition
There is also an important recent development concerning Walmsley’s career.
GSK announced in September 2025 that Luke Miels would become the company’s next CEO, assuming full responsibilities on January 1, 2026. Walmsley stepped down from the GSK board at the end of 2025 and remained with the company through September 30, 2026 to support the transition.
That means that, as of September 2026, Walmsley is no longer GSK’s CEO, although her agreed transition period was scheduled to continue through September 30, 2026.
This distinction is important when discussing her current professional status because older articles may still describe her simply as GSK’s current chief executive.
Kennedy’s Career After Raytheon
Kennedy also continued his professional involvement after leaving Raytheon Technologies.
According to recent SEC filings, Kennedy has served as a director of Textron since 2023 and has also had other roles in the corporate and investment world following his Raytheon career.
His post-Raytheon activities demonstrate how experience as the leader of a major aerospace and defense company can continue to be relevant in board-level corporate roles.
What Their Careers Tell Us About Leadership
The careers of Tom Kennedy and Emma Walmsley illustrate the importance of long-term professional development.
Kennedy’s path moved from technical engineering into operational and corporate leadership. Walmsley’s route began in international consumer marketing and progressed through healthcare management to the leadership of a major pharmaceutical company.
Their careers also show why senior executives need to understand more than one part of a business. As leaders progress, their responsibilities often expand from individual projects or departments to strategy, people, finances, operations and organizational transformation.
Neither career follows a conventional single-track template. Instead, both demonstrate how experience can accumulate over many years and eventually lead to responsibility for large international organizations.
Conclusion
Tom Kennedy and Emma Walmsley offer two distinct examples of corporate leadership.
Kennedy’s career was strongly rooted in engineering and technology before he progressed to the highest leadership positions at Raytheon and later served as executive chairman of Raytheon Technologies. Walmsley developed through international marketing and consumer business before becoming CEO of GSK and helping guide the company through a major period of transformation.
Their professional journeys are different in education, industry and specialization, yet both demonstrate the value of experience, adaptability and strategic leadership.
For anyone interested in executive careers, corporate strategy or the development of multinational businesses, examining Tom Kennedy and Emma Walmsley together provides an informative comparison of two leaders who reached the top of major organizations through very different professional routes.
READ MORE: selftimes
